TELISOTUZUMAB VEDOTIN

TELISOTUZUMAB VEDOTIN was reported 78 times

TELISOTUZUMAB VEDOTIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEUROTROPHIC KERATOPATHY 1 0.0185
1 CORNEAL DEFECT 1 0.0076
2 OCULAR SURFACE DISEASE 1 0.0036
3 CANDIDA TEST POSITIVE 1 0.0024
4 KERATITIS 6 0.0020
5 OCULAR TOXICITY 2 0.0018
6 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
7 INVESTIGATION ABNORMAL 1 0.0007
8 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
9 PULMONARY SEPSIS 1 0.0007
10 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
11 SMALL INTESTINAL HAEMORRHAGE 1 0.0005
12 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
13 PRODUCT TEMPERATURE EXCURSION ISSUE 2 0.0004
14 ULCERATIVE KERATITIS 1 0.0004
15 LUNG CANCER METASTATIC 1 0.0003
16 PRODUCT CONTAMINATION 1 0.0003
17 PNEUMONIA FUNGAL 1 0.0003
18 METASTATIC NEOPLASM 1 0.0002
19 EYE OPERATION 1 0.0002
20 INFUSION SITE EXTRAVASATION 1 0.0002
21 PRODUCT PREPARATION ISSUE 1 0.0002
22 HYPERTRANSAMINASAEMIA 1 0.0001
23 DUODENAL ULCER 1 0.0001
24 PNEUMONITIS 3 0.0001
25 PNEUMONIA BACTERIAL 1 0.0001
26 AGRANULOCYTOSIS 2 0.0001
27 INTERSTITIAL LUNG DISEASE 4 0.0001
28 NEUROPATHY PERIPHERAL 7 0.0001
29 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
30 MUSCLE TIGHTNESS 1 0.0001
31 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
32 HAEMORRHOIDS 1 0.0001
33 PRODUCT PREPARATION ERROR 1 0.0000
34 LIVER FUNCTION TEST INCREASED 1 0.0000
35 DISEASE PROGRESSION 5 0.0000
36 PANCREATIC CARCINOMA 1 0.0000
37 VISION BLURRED 4 0.0000
38 MYELOSUPPRESSION 1 0.0000
39 DYSPNOEA EXERTIONAL 1 0.0000
40 LUNG NEOPLASM MALIGNANT 1 0.0000
41 SEPTIC SHOCK 1 0.0000
42 PRODUCT STORAGE ERROR 2 0.0000
43 LIVER DISORDER 1 0.0000
44 SKIN DISCOLOURATION 1 0.0000
45 RENAL DISORDER 1 0.0000
46 PULMONARY EMBOLISM 2 0.0000
47 DRY EYE 1 0.0000
48 THERAPY CESSATION 1 0.0000
49 DEEP VEIN THROMBOSIS 1 0.0000
50 FEBRILE NEUTROPENIA 1 0.0000
51 INJECTION SITE REACTION 1 0.0000
52 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
53 UNEVALUABLE EVENT 1 0.0000
54 PNEUMONIA 4 0.0000
55 DEVICE ISSUE 1 0.0000
56 ADVERSE DRUG REACTION 1 0.0000
57 PLATELET COUNT DECREASED 1 0.0000
58 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
59 OFF LABEL USE 8 0.0000
60 SEPSIS 1 0.0000
61 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
62 CHILLS 1 0.0000
63 OEDEMA PERIPHERAL 1 0.0000
64 NEUTROPENIA 1 0.0000
65 PYREXIA 2 0.0000
66 COVID-19 1 0.0000
67 ERYTHEMA 1 0.0000
68 INCORRECT DOSE ADMINISTERED 1 0.0000
69 DEATH 3 0.0000
70 CONDITION AGGRAVATED 1 0.0000
71 FATIGUE 2 0.0000
72 VOMITING 1 0.0000
73 DYSPNOEA 1 0.0000
74 PAIN 1 0.0000
75 HEADACHE 1 0.0000
76 NAUSEA 1 0.0000
77 DRUG INEFFECTIVE 1 0.0000